| Primary |
| Glaucoma |
46.2% |
| Intraocular Pressure Increased |
12.3% |
| Open Angle Glaucoma |
8.7% |
| Hypertension |
4.8% |
| Normal Tension Glaucoma |
4.8% |
| Ocular Hypertension |
3.6% |
| Venous Occlusion |
2.7% |
| Infection Prophylaxis |
2.1% |
| Anterior Chamber Disorder |
1.8% |
| Cataract Operation |
1.5% |
| Corneal Epithelium Disorder |
1.2% |
| Developmental Glaucoma |
1.2% |
| Diabetes Mellitus |
1.2% |
| Ill-defined Disorder |
1.2% |
| Inflammation |
1.2% |
| Intraocular Pressure Test |
1.2% |
| Postoperative Care |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Cerebrovascular Accident |
0.9% |
| Hypertonia |
0.9% |
|
| Visual Acuity Reduced |
11.3% |
| Corneal Oedema |
7.2% |
| Ocular Hyperaemia |
7.2% |
| Drug Ineffective |
6.2% |
| Product Quality Issue |
6.2% |
| Toxic Epidermal Necrolysis |
6.2% |
| Anosmia |
5.2% |
| Palpitations |
5.2% |
| Rash |
5.2% |
| Visual Impairment |
5.2% |
| Blindness |
4.1% |
| Somnolence |
4.1% |
| Vision Blurred |
4.1% |
| Weight Decreased |
4.1% |
| Corneal Disorder |
3.1% |
| Eye Injury |
3.1% |
| Eye Irritation |
3.1% |
| Eye Pain |
3.1% |
| Eyelid Margin Crusting |
3.1% |
| Hypertensive Crisis |
3.1% |
|
| Secondary |
| Glaucoma |
37.7% |
| Intraocular Pressure Increased |
13.6% |
| Open Angle Glaucoma |
9.3% |
| Normal Tension Glaucoma |
7.5% |
| Venous Occlusion |
7.5% |
| Hypertension |
6.3% |
| Ill-defined Disorder |
2.7% |
| Thyroid Disorder |
2.0% |
| Anaesthesia |
1.3% |
| Developmental Glaucoma |
1.3% |
| Pain In Extremity |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Hypothyroidism |
1.2% |
| Blood Cholesterol Increased |
1.0% |
| Cerebrovascular Accident Prophylaxis |
1.0% |
| Infection Prophylaxis |
1.0% |
| Keratoconus |
1.0% |
| Ocular Hypertension |
1.0% |
| Osteoporosis |
1.0% |
| Prophylaxis |
1.0% |
|
| Eye Pain |
12.4% |
| Tinnitus |
11.6% |
| Laceration |
9.1% |
| Visual Acuity Reduced |
8.3% |
| Vitreous Opacities |
8.3% |
| Skin Exfoliation |
6.6% |
| Intraocular Pressure Increased |
5.0% |
| Ocular Hyperaemia |
4.1% |
| Scotoma |
4.1% |
| Vitreous Detachment |
4.1% |
| Intraocular Pressure Fluctuation |
3.3% |
| Raynaud's Phenomenon |
3.3% |
| Conjunctivitis Allergic |
2.5% |
| Diabetic Retinal Oedema |
2.5% |
| Diplopia |
2.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.5% |
| Ectropion |
2.5% |
| Foreign Body Sensation In Eyes |
2.5% |
| Glaucoma |
2.5% |
| Iritis |
2.5% |
|
| Concomitant |
| Glaucoma |
23.5% |
| Drug Use For Unknown Indication |
14.7% |
| Product Used For Unknown Indication |
10.6% |
| Hypertension |
9.3% |
| Breast Cancer |
4.4% |
| Diabetes Mellitus |
3.8% |
| Prophylaxis |
3.6% |
| Pain |
3.4% |
| Multiple Myeloma |
3.0% |
| Type 2 Diabetes Mellitus |
2.9% |
| Juvenile Idiopathic Arthritis |
2.8% |
| Asthma |
2.6% |
| Depression |
2.5% |
| Osteoporosis |
2.3% |
| Arthritis |
1.9% |
| Atrial Fibrillation |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Constipation |
1.5% |
|
| Intraocular Pressure Increased |
13.4% |
| Visual Acuity Reduced |
10.8% |
| Vomiting |
8.2% |
| Weight Decreased |
7.2% |
| Wheezing |
6.2% |
| Vision Blurred |
5.2% |
| Dyspnoea |
4.6% |
| Hyponatraemia |
4.6% |
| Thrombocytopenia |
4.1% |
| Death |
3.6% |
| Nausea |
3.6% |
| Visual Disturbance |
3.6% |
| Visual Field Defect |
3.6% |
| Fall |
3.1% |
| Malaise |
3.1% |
| Retinal Vein Occlusion |
3.1% |
| Somnolence |
3.1% |
| Stupor |
3.1% |
| Weight Increased |
3.1% |
| Dehydration |
2.6% |
|
